Links

Homepage

Stock List

Search by Ticker

News

Login

Edwards Lifesciences Corporatio (NYSE:EW)
Stock Analysis

EW72.48
▼ -0.14%-0.1

Stock Analysis

The following stock analysis is based on 9.2 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.

Stock Exchange

Edwards Lifesciences Corporatio trades on the NYSE exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Edwards Lifesciences Corporatio

It is currently trading at $72.48 ($72.58 the previous day).

Financials

The next reporting date is in 55 days (2023 02 02).

CNN estimates profits for the upcoming quarter will be $0.61 per share ($1.3B). The current Canada / US exchange rate is 1.3589.



Over the past 12 months, $0 worth of shares have been purchased and $58226350 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 12.9% per year assuming steady exponential growth. The actual 5 year average is 24.82. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year103.094008679251.3- Below Average
2 year101.8132892592632.9+ Above Average
3 year76.58398993506515.5- Below Average
4 year66.28508130081341.3+ Above Average
5 year46.91383141762533.1+ Above Average
Edwards Lifesciences Corporatio is projected by analysts to get to $94.50 within the next 12 months (30.4%), but preticted targets range from as high as $105.00 (44.9%) and as low as $73(0.7%).

Risk

The worst drop it has had in recent years is -48.0%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.

Stock shape test

DAYS AG0PRICE
1076.36DROPPING
3068.54RISING
6084.315DROPPING
15098.36DROPPING
365111.985DROPPING
80077.45RISING
120070.68RISING
160050.87RISING
200038.33RISING
!!!!!!!!!!!! WARNING STOCK DROPPING !!!!!!!!!!!!!!!!!

With an average increase of 12.9% year over year, if Edwards Lifesciences Corporatio is bought at the worst time, Stockmarketizer analysts estimate it will take 44.7 months before the stock will recover to the original purchase price. The P/E value is 31.11. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Description

Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.

The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.

Tradingview BuySell Widget

Yahoo News Feed

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE

Thu, 08 Dec 2022 13:01:00 Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance1 today during its annual investor conference.... Read Full Article

EDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN

Thu, 08 Dec 2022 13:00:00 Edwards Lifesciences Corporation (NYSE: EW) today announced that following regular succession planning discussions with the Board of Directors, Edwards' chairman and CEO, Michael A. Mussallem, who recently turned 70, has informed the Board of his decision to retire as CEO in ...... Read Full Article

EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

Sun, 27 Nov 2022 15:25:00 Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company's EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes. The data were presented ...... Read Full Article

Could The Market Be Wrong About Edwards Lifesciences Corporation (NYSE:EW) Given Its Attractive Financial Prospects?

Wed, 16 Nov 2022 18:24:13 It is hard to get excited after looking at Edwards Lifesciences' (NYSE:EW) recent performance, when its stock has...... Read Full Article

Zoetis, CVS, and 3 More Healthcare Stocks With Room to Climb

Wed, 16 Nov 2022 13:44:00 Zoetis and Medtronic are among the healthcare stocks with the most room to rise, according to Wall Street analysts' average price targets.... Read Full Article

10 Best 52-Week Low Stocks To Buy Now

Mon, 14 Nov 2022 17:14:22 In this article we present the list of 10 Best 52-Week Low Stocks To Buy Now. Click to skip ahead and see the 5 Best 52-Week Low Stocks To Buy Now. Microsoft Corporation (NASDAQ:MSFT), Amazon.com, Inc. (NASDAQ:AMZN), and Meta ...... Read Full Article

EDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED SHARE REPURCHASE

Tue, 01 Nov 2022 13:00:00 Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $750 million of Edwards' common stock. With this transaction, Edwards has repurchased more than $1.7 billion of shares in 2022.... Read Full Article

7 Stocks to Buy at the ‘Midterm Elections’ Bottom

Mon, 31 Oct 2022 16:01:53 Although the concept of stocks to buy at the ‘midterm elections’ bottom seems farfetched considering the broader volatility this year, the calendar might provide a change of heart. According to The New York Times, the U.S. equities sector generally ...... Read Full Article

Edwards Plummets After Slashing Profit Guidance As Challenges Mount In The U.S.

Fri, 28 Oct 2022 20:05:22 Edwards slashed its profit outlook, leading EW stock to plummet Friday amid continued hospital staffing and exchange-rate challenges.... Read Full Article

Why Edwards Lifesciences Stock Crashed 16% Today

Fri, 28 Oct 2022 17:14:37 Shares of medical device maker Edwards Lifesciences (NYSE: EW) fell 16.6% through 11:45 a.m. ET on Friday even though the company missed analyst targets for third-quarter earnings last night by only the slimmest of margins. Analysts had forecast that Edwards would ...... Read Full Article

Edwards Lifesciences (EW) Q3 Earnings Miss, Margins Rise

Fri, 28 Oct 2022 17:08:05 Edwards Lifesciences (EW) continues to register strong momentum in TMTT on a portfolio of differentiated therapies, positive pivotal trial results and favorable real-world clinical outcomes.... Read Full Article

Economic Challenges Hit Edwards Lifesciences Q3 Earnings, Guidance Lags Wall Street Estimates

Fri, 28 Oct 2022 16:25:48 Edwards Lifesciences Corp (NYSE: EW) reported Q3 adjusted EPS of $0.61, up 13% Y/Y, missing the Wall Street consensus of $0.62. The company saw persistent U.S. hospital staffing shortages and COVID headwinds in Japan affect its TAVR sales. Edwards' TAVR sales ...... Read Full Article

Edwards Lifesciences Is Seeing Downside Price Targets

Fri, 28 Oct 2022 14:35:00 Heart-focused medical device maker Edwards Lifesciences reported a Non-GAAP EPS of $0.61 which missed by $0.01, revenue of $1.32B which missed by $10M. EW has revised their guidance for 2022. A number of fundamental analysts have cut their price targets.... Read Full Article

Edwards Lifesciences (EW) Lags Q3 Earnings and Revenue Estimates

Thu, 27 Oct 2022 21:35:09 Edwards Lifesciences (EW) delivered earnings and revenue surprises of -1.61% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

Thu, 27 Oct 2022 20:15:00 Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2022.... Read Full Article

Analysts Estimate Integer (ITGR) to Report a Decline in Earnings: What to Look Out for

Thu, 20 Oct 2022 14:02:02 Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022

Thu, 20 Oct 2022 11:05:00 Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2022 after the market closes on Thursday, October 27, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss those results.... Read Full Article

Edwards Lifesciences (EW) to Report Q3 Results: Wall Street Expects Earnings Growth

Wed, 19 Oct 2022 14:01:02 Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article

Intuitive Surgical, Inc. (ISRG) Surpasses Q3 Earnings and Revenue Estimates

Tue, 18 Oct 2022 21:35:09 Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 8.18% and 2.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?

Tue, 18 Oct 2022 15:57:03 Within the TAVR arm, Edwards Lifesciences (EW) is likely to have witnessed continued growth in procedures across the United States and worldwide.... Read Full Article
<